- Report
- January 2021
- 199 Pages
From €3029EUR$3,554USD£2,690GBP
€3365EUR$3,949USD£2,989GBP
- Report
- March 2020
- 120 Pages
From €3000EUR$3,771USD£2,758GBP
- Report
- January 2021
- 900 Pages
From €2390EUR$2,805USD£2,123GBP
€2812EUR$3,300USD£2,498GBP
- Report
- July 2020
- 93 Pages
From €728EUR$854USD£646GBP
€809EUR$949USD£718GBP
- Clinical Trials
- January 2020
- 1140 Pages
From €2557EUR$3,000USD£2,271GBP
- Report
- July 2019
- 154 Pages
From €3537EUR$4,150USD£3,141GBP
- Report
- March 2019
- 110 Pages
From €3578EUR$4,199USD£3,178GBP
- Report
- September 2016
- 130 Pages
From €1534EUR$1,800USD£1,362GBP
- Drug Pipelines
- October 2013
- 480 Pages
From €1534EUR$1,800USD£1,362GBP
- Report
- January 2021
- 181 Pages
From €3029EUR$3,554USD£2,690GBP
€3365EUR$3,949USD£2,989GBP
- Report
- January 2021
- 183 Pages
From €3029EUR$3,554USD£2,690GBP
€3365EUR$3,949USD£2,989GBP
From €1014EUR$1,190USD£901GBP
- Report
- January 2021
- 143 Pages
From €3000EUR$3,771USD£2,758GBP
- Report
- January 2021
- 143 Pages
From €3000EUR$3,771USD£2,758GBP
- Report
- January 2021
- 143 Pages
From €3000EUR$3,771USD£2,758GBP
- Report
- January 2021
- 2085 Pages
€3281EUR$3,850USD£2,914GBP
- Report
- January 2021
- 2040 Pages
€3281EUR$3,850USD£2,914GBP
- Report
- January 2021
- 2016 Pages
€3281EUR$3,850USD£2,914GBP
- Report
- January 2021
- 2179 Pages
€3281EUR$3,850USD£2,914GBP
- Report
- January 2021
- 2006 Pages
€3281EUR$3,850USD£2,914GBP

Over a million women worldwide are diagnosed with breast cancer annually. Alongside surgery, radiotherapy and immunotherapy, pharmaceutical products (including hormonal therapy and chemotherapy) are in the frontline against this terrible disease. Market reports in this section enable buyers to read up on the latest breast cancer drug pipelines and R&D strategies, as well as the medical and commercial activities of major players and niche operators such Abraxis Bioscience, Aeterna Zentaris, Agendia BV, Aphton Corp, Array BioPharma, AstraZeneca Plc, Bristol Myers Squibb, Dendreon Corporation, Eli Lilly, Genentech, Genta, Novartis AG, Pfizer, Roche Group, Sanofi-Aventis, Schering AG, Therion Biologics, and ViRexx Medical. Also included are cutting edge academic journals and various expert textbooks for medical professionals involved in breast cancer treatment. Show Less Read more